Caring for the adult with sickle cell disease: Results of a multidisciplinary pilot program

Journal of the National Medical Association

Volumn 102, Issue 11, 2010, Pages 1009-1016

  Artz, Nicole ^a   Whelan, Chad ^a   Feehan, Sharon ^b  

^a LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Sickle cell disease; Utilization

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYUREA; PNEUMOCOCCUS VACCINE;

ARTICLE; HEALTH PROGRAM; HOSPITAL ADMISSION; HOSPITAL READMISSION; HUMAN; INFLUENZA VACCINATION; IRON OVERLOAD; LENGTH OF STAY; LONG TERM CARE; PATIENT CARE; PILOT STUDY; PRIORITY JOURNAL; PROTEINURIA; SICKLE CELL ANEMIA;

EID: 78650122303     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-9684(15)30727-6     Document Type: Article

References (24)

1. Telfer P, Coen P, Chakravorty S, et al. Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London. Haematologica. 2007;92:905-912.
2. Sickle Cell Disease Patients in US Hospitals. 2004. Agency for Healthcare Research and Qualify.
3. Malach S, Levin T, Saravay S, Martin R, Rao S, Horowitz D. Sickle cell disease - when opioids and physicians fail. Gen Hosp Psychiatry. 2002;24:442-447.
4. Pack-Mabien A, Labbe E, Herbert D, Haynes J, Jr. Nurses' attitudes and practices in sickle cell pain management. Appl Nurs Res. 2001;14:187-192.
5. Shapiro BS, Benjamin LJ, Payne R, Heidrich G. Sickle cell-related pain: perceptions of medical practitioners. J Pain Symptom Manage. 1997;14:168-174.
6. Sutton M, Atweh GF, Cashman TD, Davis WT. Resolving conflicts: misconceptions and myths in the care of the patient with sickle cell disease. Mt Sinai J Med. 1999;66:282-285.
7. Waldrop RD, Mandry C. Health professional perceptions of opioid dependence among patients with pain. Am J Emerg Med. 1995;13:529-531.
8. Lanzkron S, Haywood Jr C, Segal JB, Dover GJ. Hospitalization rates and costs of care of patients with sickle-cell anemia in the state of Maryland in the era of hydroxyurea. Am J Hematol. 2006;81:927-932. (Pubitemid 44864450)
9. A Sickle Crisis? A report of the National Confidential Inquiry into Patient Outcome and Death 2008.
10. Smith LA, Oyeku SO, Homer C, Zuckerman B. Sickle cell disease: a question of equity and quality. Pediatrics. 2006;117:1763-1770. (Pubitemid 46071409)
11. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness: the chronic care model, Part 2. JAMA. 2002;288:1909-1914.
12. The Management of Sickle Cell Disease. Washington, DC: Government Printing Office; 2004. US Department of Health and Human Services publication NIH 04-2117.
13. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness. JAMA. 2002;288:1775-1779.
14. Wagner EH. Chronic disease management: what will it take to improve care for chronic illness? Eff Clin Pracr. 1998;1:2-4.
15. Wagner EH, Austin BT, Davis C, Hindmarsh M, Schaefer J, Bonomi A. Improving chronic illness care: translating evidence into action. Health Aff (Millwood). 2001;20:64-78.
16. Wagner EH, Austin BT, Von Korff M. Organizing care for patients with chronic illness. Milbank Q. 1996;74:511-544.
17. Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med. 1995;332:1317-1322.
18. Steinberg MH, Barton F, Castro O, et al. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. JAMA. 2003;289:1645-1651.
19. Platt OS. Hydroxyurea for the treatment of sickle cell anemia. N Engl J Med. 2008;358:1362-1369.
20. Fitzhugh CD, Wigfall DR, Ware RE. Enalapril and hydroxyurea therapy for children with sickle nephropathy. Pediatr Blood Cancer. 2005;45:982-985. (Pubitemid 41552170)
21. Guasch A, Navarrete J, Nass K, Zayas CF. Glomerular involvement in adults with sickle cell hemoglobinopathies: Prevalence and clinical correlates of progressive renal failure. J Am Soc Nephrol. 2006;17:2228-2235.
22. Foucan L, Bourhis V, Bangou J, Merault L, Etienne-Julan M, Salmi RL. A randomized trial of captopril for microalbuminuria in normotensive adults with sickle cell anemia. Am J Med. 1998;104:339-342.
23. Ataga KI, Moore CG, Jones S, et al. Pulmonary hypertension in patients with sickle cell disease: a longitudinal study. Br J Haematol. 2006;134:109-115.
24. Gladwin MT, Sachdev V, Jison ML, et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med. 2004;350:886-895. (Pubitemid 38252536)